Evidence-Based Innovation 1.0 Event in St. Louis
Evidence-Based Innovation 1.0 Event in St. Louis
All SLMMS members have been extended a special invitation by iSelect Fund to attend Evidence-Based Innovation 1.0, an evening of unprecedented access and insight, on Tuesday, November 3, from 6:30-8:30 p.m. at the CIC@4240 building in the heart of the Cortex Innovation Community in St. Louis.
For the first time ever, the healthcare community and anyone interested in healthcare innovation will have unprecedented access to over 20 bio-tech companies that will change the future of healthcare. Directly engage with forward-thinking chemists, CEOs and creative disruptors who are changing the healthcare landscape. Discover cutting-edge technology that will shape the next generation of medicine.
Evidence-Based Innovation 1.0 is the joint effort of iSelect, Express Scripts, IDEA Labs, EPharmix, BioGenerator, Metaphase and the Cortex Innovation Community.
WHEN
Tuesday, November 3, 2015 from 6:30 to 8:30 p.m.
WHERE
CIC St. Louis – 4240 Duncan Avenue #200, St. Louis MO 63110
Hors d’oeuvres and cocktails will be served. This event is free.
Questions? For more information, contact Renee Moore at 314-223-7960 or renee@iselectfund.com
This event is not sponsored by the St. Louis Metropolitan Medical Society. However, all SLMMS members are invited to this exclusive event, and are encouraged to explore this opportunity.
